Regulatory agencies are increasingly collaborating to harmonize guidelines and standards. The FDA and EMA, for example, have issued specific guidelines for the evaluation of nanomedicines. Additionally, initiatives like the Nanotechnology Characterization Laboratory (NCL) work to develop standardized testing protocols.
